These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 20373114)
1. Meta-analysis: somatostatin or its long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis. Omata F; Deshpande G; Tokuda Y; Takahashi O; Ohde S; Carr-Locke DL; Jacobs JL; Mine T; Fukui T J Gastroenterol; 2010 Aug; 45(8):885-95. PubMed ID: 20373114 [TBL] [Abstract][Full Text] [Related]
2. [Meta-analysis: somatostatin for prophylaxis against post endoscopic retrograde cholangiopancreatography pancreatitis]. Pan SB; Geng XP Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):466-472. PubMed ID: 27938583 [No Abstract] [Full Text] [Related]
3. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study. Andriulli A; Caruso N; Quitadamo M; Forlano R; Leandro G; Spirito F; De Maio G JOP; 2003 Jan; 4(1):41-8. PubMed ID: 12555015 [TBL] [Abstract][Full Text] [Related]
4. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Andriulli A; Leandro G; Niro G; Mangia A; Festa V; Gambassi G; Villani MR; Facciorusso D; Conoscitore P; Spirito F; De Maio G Gastrointest Endosc; 2000 Jan; 51(1):1-7. PubMed ID: 10625786 [TBL] [Abstract][Full Text] [Related]
5. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results. Poon RT; Fan ST JOP; 2003 Jan; 4(1):33-40. PubMed ID: 12555014 [TBL] [Abstract][Full Text] [Related]
6. Endoscopic and pharmacological treatment for prophylaxis against postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis and systematic review. Vadalà di Prampero SF; Faleschini G; Panic N; Bulajic M Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1415-1424. PubMed ID: 27580214 [TBL] [Abstract][Full Text] [Related]
7. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy. Arcidiacono R; Gambitta P; Rossi A; Grosso C; Bini M; Zanasi G Endoscopy; 1994 Nov; 26(9):715-8. PubMed ID: 7536155 [TBL] [Abstract][Full Text] [Related]
8. Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography. Tulassay Z; Döbrönte Z; Prónai L; Zágoni T; Juhász L Aliment Pharmacol Ther; 1998 Nov; 12(11):1109-12. PubMed ID: 9845400 [TBL] [Abstract][Full Text] [Related]
9. Somatostatin for prevention of post-ERCP pancreatitis: a randomized, double-blind trial. Concepción-Martín M; Gómez-Oliva C; Juanes A; Díez X; Prieto-Alhambra D; Torras X; Sainz S; Villanueva C; Farre A; Guarner-Argente C; Guarner C Endoscopy; 2014 Oct; 46(10):851-6. PubMed ID: 24977398 [TBL] [Abstract][Full Text] [Related]
10. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Andriulli A; Clemente R; Solmi L; Terruzzi V; Suriani R; Sigillito A; Leandro G; Leo P; De Maio G; Perri F Gastrointest Endosc; 2002 Oct; 56(4):488-95. PubMed ID: 12297762 [TBL] [Abstract][Full Text] [Related]
11. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: A systematic review and meta-analysis. Wang G; Xiao G; Xu L; Qiu P; Li T; Wang X; Wen P; Wen J; Xiao X Pancreatology; 2018 Jun; 18(4):370-378. PubMed ID: 29550097 [TBL] [Abstract][Full Text] [Related]
12. Post-ERCP pancreatitis. Arata S; Takada T; Hirata K; Yoshida M; Mayumi T; Hirota M; Yokoe M; Hirota M; Kiriyama S; Sekimoto M; Amano H; Wada K; Kimura Y; Gabata T; Takeda K; Kataoka K; Ito T; Tanaka M J Hepatobiliary Pancreat Sci; 2010 Jan; 17(1):70-8. PubMed ID: 20012323 [TBL] [Abstract][Full Text] [Related]
13. The use of long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy. Tenner SM; Van Dam J Gastrointest Endosc; 1995 Nov; 42(5):497-8. PubMed ID: 8566651 [No Abstract] [Full Text] [Related]
14. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Andriulli A; Leandro G; Federici T; Ippolito A; Forlano R; Iacobellis A; Annese V Gastrointest Endosc; 2007 Apr; 65(4):624-32. PubMed ID: 17383459 [TBL] [Abstract][Full Text] [Related]
15. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial. Poon RT; Yeung C; Liu CL; Lam CM; Yuen WK; Lo CM; Tang A; Fan ST Gut; 2003 Dec; 52(12):1768-73. PubMed ID: 14633959 [TBL] [Abstract][Full Text] [Related]
16. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate. Andriulli A; Solmi L; Loperfido S; Leo P; Festa V; Belmonte A; Spirito F; Silla M; Forte G; Terruzzi V; Marenco G; Ciliberto E; Sabatino A; Monica F; Magnolia MR; Perri F Clin Gastroenterol Hepatol; 2004 Aug; 2(8):713-8. PubMed ID: 15290665 [TBL] [Abstract][Full Text] [Related]
17. Prophylactic octreotide administration does not prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials. Bai Y; Gao J; Zou DW; Li ZS Pancreas; 2008 Oct; 37(3):241-6. PubMed ID: 18815543 [TBL] [Abstract][Full Text] [Related]
18. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial. Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687 [TBL] [Abstract][Full Text] [Related]
19. [Utility of bolus somatostatin administration in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a controlled, non-randomized study]. Vila JJ; Jiménez FJ; Prieto C; Borobio E; Juanmartiñena JF; Borda F Gastroenterol Hepatol; 2006 Apr; 29(4):231-6. PubMed ID: 16584693 [TBL] [Abstract][Full Text] [Related]